U.S. Markets open in 7 hrs 46 mins

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8800+0.0900 (+3.23%)
At close: 4:00PM EST

Agile Therapeutics, Inc.

101 Poor Farm Road
Princeton, NJ 08540
United States
609 683 1880
http://www.agiletherapeutics.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees15

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman, Pres & CEO971.11kN/A1959
Mr. Geoffrey P. GilmoreSr. VP, Gen. Counsel & Corp. Sec.592.28kN/A1966
Mr. Robert G. ConwaySr. VP & Chief Supply Chain Officer444.11kN/A1957
Mr. Dennis P. ReillySr. VP & CFON/AN/A1959
Ms. Tristen HerrstromSr. VP of HR & Admin.N/AN/AN/A
Matthew RileyHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Amy WelshVP of MarketingN/AN/AN/A
Ms. Kimberly WhelanVP of Sales & Market AccessN/AN/AN/A
Dr. Elizabeth Ijeoma Onyemelukwe GarnerConsultantN/AN/A1968
Dr. Paul KornerChief Medical OfficerN/AN/A1966
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, focuses on the research, development, and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter and lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of November 2, 2019 is 8. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.